Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s | Zendy

Grace A. McComsey | Zendy; Douglas Kitch | Zendy; Paul E. Sax | Zendy; Pablo Tebas | Zendy; C. Tierney | Zendy; Nasreen C. Jahed | Zendy; L.E. Myers | Zendy; Katherine Melbourne | Zendy; B. Ha | Zendy; Eric S. Daar | Zendy

Open Access

Peripheral and Central Fat Changes in Subjects Randomized to Abacavir-Lamivudine or Tenofovir-Emtricitabine With Atazanavir-Ritonavir or Efavirenz: ACTG Study A5224s

Author(s) -

Grace A. McComsey,

Douglas Kitch,

Paul E. Sax,

Pablo Tebas,

C. Tierney,

Nasreen C. Jahed,

L.E. Myers,

Katherine Melbourne,

B. Ha,

Eric S. Daar

Publication year - 2011

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cir324

Subject(s) - abacavir , efavirenz , medicine , atazanavir , emtricitabine , lipoatrophy , ritonavir , lamivudine , clinical endpoint , stavudine , gastroenterology , lopinavir , randomized controlled trial , viral load , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , hepatitis b virus , virus

We compare the effect of 4 different antiretroviral regimens on limb and visceral fat.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research